Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(2)

Detailed Status

Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting133%
completed267%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge

NCT05056844
completednot_applicable

Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion

NCT05036083
completed

Follow-up Study to Previous CARE Trial

NCT00479024

Clinical Trials (3)

Showing 3 of 3 trials
NCT05056844Not Applicable

Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge

Recruiting
NCT05036083Not Applicable

Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion

Completed
NCT00479024

Follow-up Study to Previous CARE Trial

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3